Evidence map›Paper›PMID 41634249›Full record

ArticleMikrochimica acta2026

Immunochromatographic SERS sensor-deep learning combined strategy for intelligent diagnosis of chronic kidney disease.

Zengshan Yu, Zhibin Zhang, Shan Guo, Zelong Li, Hao Chen, Jichuan Gai, Jiyuan Wei, Shiqi Xu, Mingli Wang, Guochao Shi

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zengshan Yu *Hebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, 067000, Hebei, China.
Zhibin Zhang *College of Traditional Chinese Medicine, Chengde Medical University, Chengde, 067000, Hebei, China.
Shan GuoHebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, 067000, Hebei, China.
Zelong LiHebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, 067000, Hebei, China.
Hao ChenHebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, 067000, Hebei, China.
Jichuan GaiHebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, 067000, Hebei, China.
Jiyuan WeiHebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, 067000, Hebei, China.
Shiqi XuHebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, 067000, Hebei, China. xsq@cdmc.edu.cn.
Mingli WangState Key Laboratory of Metastable Materials Science and Technology, Key Laboratory for Microstructural Material Physics of Hebei Province, School of Science, Yanshan University, Qinhuangdao, 066000, China. wml@ysu.edu.cn.
Guochao ShiHebei Key Laboratory of Nerve Injury and Repair, Chengde Medical University, Chengde, 067000, Hebei, China. sgc@cdmc.edu.cn.

Funding

Science Research Project of Hebei Education Department BJ2025135the project of the Graduate Student Innovation Ability Training of Education of Hebei Province Department CXZZSS2026134
6 · The paper itself

Abstract

A combined "immunochromatographic surface-enhanced Raman scattering (SERS) sensor-deep learning" detection strategy is proposed. Specifically, we first prepared an immunochromatographic SERS sensor with excellent surface enhancement capability for the specific recognition of neutrophil gelatinase-associated lipocalin (NGAL) molecules in serum, significantly enhancing the detection sensitivity of the target molecule. Subsequently, we integrated deep learning algorithms to perform preprocessing, feature extraction, and pattern recognition analysis on complex SERS spectral signals, overcoming the limitations of traditional algorithms in handling high-dimensional nonlinear data. This approach enables rapid, sensitive, and highly specific detection of NGAL. The platform achieves a detection limit as low as 0.1059 ng/mL with a broad linear detection range. For clinical validation, serum samples from 14 volunteers were analyzed. Six deep learning models were employed to classify the acquired clinical spectral data, with the Residual Network (ResNet) model achieving a classification accuracy of 98.81%, a loss value of only 0.0877, and an area under the receiver operating characteristic curve (AUC) of 99.97%. In addition, in the analysis of new samples, the classification and prediction of data from patients and normal individuals were successfully achieved. The proposed "immunoassay surface-enhanced Raman scattering sensor - deep learning" combined detection strategy has demonstrated extraordinary potential in the rapid, sensitive and specific detection of NGAL, providing crucial technical support for the intelligent discrimination of chronic kidney disease.

Indexed as

Chromatography, AffinityDeep LearningLipocalin-2Renal Insufficiency, ChronicSpectrum Analysis, RamanGoldHumansImmunoassayLimit of DetectionGoldLCN2 protein, humanLipocalin-2Au NPsChronic kidney deseaseDeep learningImmunosensorNGALSERS

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.